Nyhet -

Intelligent Simplicity is the way to go with dental implants

Neoss is a pioneer in complete solutions for dental implants based on a single platform. With a single prosthetic platform, a simplicity of the system is guaranteed, which makes it easier for the dentists to learn, and which dramatically streamlines the work in the clinic. Neoss is now expanding further by strengthening their presence in USA and China.

Although the Neoss implant system is based on a single prosthetic platform, all types of dental cases can be solved, even the most advanced ones that require several different solutions.

“Now we see that the development of new systems in dental implants is going in this direction as well. You want simpler systems, but which are at the same time so advanced that all forms of dental cases can be solved. It is all about working in a smarter way, and we coined that statement early with our motto Intelligent Simplicity”, Dr Robert Gottlander, Neoss CEO, explains.

Still going strong in Gothenburg

Like all implant systems, Neoss’ system is based on the discovery that Professor Per-Ingvar Brånemark made and which he called osseointegration. Neoss has conducted further research in the field for several decades and has long-term follow-up on the results of using their system.

All product development within Neoss still takes place in Gothenburg, where the head office is also located. All implants are manufactured in Sweden, and that is also something that distinguishes Neoss from competitors today.

“We still live according to Brånemark’s vision and spirit; “No one should die with their teeth in a glass of water”. We want to create dignity for patients and offer good treatments based on simplicity, just like Brånemark did”, says Gottlander.

Taking on the world’s largest markets

The world’s largest markets for dental implants are the USA, Brazil and China. Neoss is now developing its business in two of them, namely in the USA and China.

In 2022, the strategy within Neoss has changed significantly so that the company can develop towards the largest markets. In the USA, a new organisation for sales and marketing has been established. In China, Neoss has recently bought out its distributor to get closer to customers with its own sales channels.

The development continues

For Neoss, Gothenburg is still the global capital for dental implants.

“We will continue to develop our products and our business from Gotheburg. We have launched many novelties over the years, and we continue to refine the range all the time”, Gottlander states.

An example is the development of the NeoScan 1000, a camera that is used to take digital prints of patient’ teeth, instead of manually making impressions using modelling paste. Neoss showcased the NeoScan 1000 during Neoss Integrate 2022, a fair where over 600 dental professionals were gathered in Gothenburg in June 2022.

“There is no doubt in my mind that we will continue to lead the development of smart dental solutions to help dental professionals treat their patients smarter and better, and now also by taking on the world by strengthening our presence in the USA and China”, says Robert Gottlander.

Relaterade länkar

Ämnen

  • Ekonomi, finans

Kategorier

  • gothenburg life science

Regioner

  • Västra Götaland

Kontakter

Relaterad media

Relaterat innehåll

  • Founding Partner Mölnlycke Health Care will move to GoCo in 2024

    Mölnlycke Health Care stands for innovation and quality. This is also a strongly contributing reason why all Gothenburg-based operations within Mölnlycke will move to GoCo Health Innovation City at the end of 2024.
    All stakeholders in medicine and health technology have a comprehensive responsibility to help healthcare reach the next level with better products and more effective solutions.

  • A new giant is born with GoCo Health Innovation City

    Within a few years, between 8,000 and 10,000 jobs will be created in the GoCo Health Innovation City.
    Just like the BioVentureHub and the innovation environment there, GoCo Health Innovation City has been created on the initiative of AstraZeneca.
    In the beginning there was a giant
    It started with the pharmaceutical giant, AstraZeneca looking to sell some of their land connecting to thei

  • Internet of Things gives personalised incontinence care

    The world is changing and the demand for innovative hygiene and health products is increasing at a high speed. Pressure on healthcare funding and staff, the acceleration of home care and an increasing importance of sustainability consumerization are three major trends within the health and medical area looking into the future.
    Essity, who is the leading global player in incontinence products wi

  • Key2Compliance excels in QA Services

    Key2Compliance can help companies in the pharmaceutical, medical device and in vitro diagnostic industry to avoid the pitfalls that regulatory requirements may present. With a strong offer in Quality Assurance, Key2Compliance can help clients reach the next level – all the way from development to commercial phase.
    For individual innovators or SMEs, it can be difficult to keep track of the regul

  • Kromnigon takes multi-colour microscopy to a new level

    A company based on innovative thinking can be a real game-changer. The founders of Kromnigon have worked with existing technologies and made important upgrades and modifications to create all new possibilities in multi-colour microscopy. This will for example benefit the development of immunotherapy treatments.
    Microscopy is a proven technique that has been around for a long time due to its ab

  • Circius Pharma is a “New” Swedish company with development in both medtech and pharma

    The company is named after a powerful northern wind. Founder Jan G. Smith
    appreciated the symbolism of being a northern firm and growing like a forceful northern wind.
    Over 30 years ago, Jan G. Smith founded Abigo Medical, a successful company also known worldwide thanks to its unique wound care product Sorbact. Jan now transfers decades of knowledge to Circius Pharma, a family owned compan

  • TATAA Biocenter to offer GLP services to developers of cell and gene therapies across the world

    TATAA Biocenter was first to develop PCR technology in Sweden and was also a pioneer by offering covid tests at the very beginning of the outbreak of the pandemic. TATAA Biocenter is now building Europe’s most modern laboratory for molecular analyses in Gothenburg.
    The team behind TATAA Biocenter has worked with molecular analyses for over 30 years. The company was established around 20 years a

Fyll i din epostadress för att följa Affärstidningen Näringsliv

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Affärstidningen Näringsliv.

Okej